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Introduction
Focal liver lesions can be defined as any lesion in the
liver other than the normal parenchyma with or without
causing structural and functional abnormality of
hepatobiliary system and can be of variable size. These
lesions can be benign or malignant. Prevalence of various
liver lesions has marked differences across geographic
regions and ethnic groups.1 Focal liver lesion is more likely
to represent a metastatic deposit than primary malignancy in
Europe and United States; however, hepatocellular carcinoma
is the fourth most common hepatic disorder in Pakistan with
prevalence of 8-10%. This prevalence rate is high when
compared to western data.2,3
In a patient without known cancer or history of
chronic liver disease, these lesions usually can be evaluated
with serial follow-up imaging tests because nearly all will be
benign. In patients with cancer, however, prompt
determination of the cause of such lesions may be pivotal for
defining prognosis and therapy. Small hepatic lesions were
deemed benign in 51% of the 82% of patients with a known
underlying malignancy.4 Benign hepatic tumours have been
reported in up to 52% of the general population.5 It is
therefore important to differentiate between benign and
malignant focal liver lesions for further management of the
patient. 
It is often difficult to characterize hepatic lesions with
various imaging studies. Although histopathology is the gold
standard, biopsy is always not possible as it is an invasive
technique. Computed tomography (CT) is the imaging
modality most often used to evaluate focal liver lesions,
however, the complex blood supply of the liver frustrates the
search for an optimal contrast-enhanced CT protocol for the
detection and characterization of focal hepatic lesions.
Although the liver receives approximately 30% of its blood
supply from the hepatic artery and 70% from the portal vein,
most primary and secondary liver neoplasms receive 80-95%
of their blood supply from the hepatic artery. Because of the
high frequency of benign focal liver lesions such as cysts,
haemangiomas and focal nodular hyperplasia,
characterization of these lesions is essential. Consequently,
the preferred liver CT technique should combine a high
sensitivity for lesion detection with a good ability for lesion
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Abstract
Objective: To assess the diagnostic accuracy of triphasic spiral CT in differentiating benign from malignant focal
tumoral liver lesions.
Methods: The study was conducted in Department of Radiology of Aga Khan University Hospital and Sind
Institute of Urology and Transplantation, Karachi from Feb 2006 to Feb 2007. By convenient sampling, 45
patients found to have focal tumoral liver lesions were recruited for one year period and their triphasic CT scans
findings were evaluated and later correlated with histopathology. Sensitivity, specificity, positive predictive value,
negative predictive value and diagnostic accuracy of triphasic CT scan were calculated.
Results: Among 45 patients, 136 liver lesions (11 benign and 125 malignant) were detected with the help of
different enhancement patterns. Out of these, 37(82.2%) patients had malignant while 8 (17.8%) had benign
lesions. On later histopathological examination, 35 (77.8%) of the total 45 cases had malignant lesions while 10
(22.2%) were diagnosed as benign lesions. Based on these results, it could be assessed that triphasic CT Scan
has a sensitivity of 100 %, specificity of 80%, positive predictive value of 94.5%, negative predictive value of
100% and diagnostic accuracy of 95.5 % in differentiating benign from malignant liver lesions.
Conclusion: Triphasic CT Scan is a good non-invasive tool in characterizing and differentiating benign from
malignant liver lesions. 
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characterization, to differentiate lesions that do need further
diagnostic tests or treatment for lesions that do not. To meet
these requirements, a triphasic spiral CT technique was
developed to image the entire liver in arterial, portal, and
equilibrium phases.6,7 Although current literature search
shows that MRI has a comparable rate in detection and
classification of focal liver lesions, however, rapid
availability and short scanning time made CT an ideal
imaging technique.8-10 Recent studies have also reported an
improvement in lesion detection if arterial phase imaging is
performed in addition to portal venous imaging especially in
the presence of hypervascular neoplasms, such as
hepatocellular carcinoma.11-13
In the current study, we evaluated a triphasic spiral
computed tomogram technique that allowed imaging of the
entire liver in arterial, portal and equilibrium phases.6-9 The
rationale behind the protocol is that the portal phase is the
most sensitive phase for lesion detection, whereas the arterial
and equilibrium phases can supply additional information on
the vascularity of the lesion which may help to identify the
nature of lesion.10-14 The vascular haemodynamics is the key
to detect characterization of hypervascular lesions. 
Several studies have been done worldwide on the role
of triphasic CT scan in characterizing and differentiating
benign and malignant lesions. However, to the best of our
knowledge, no data has been published locally, so purpose of
this study was to describe the role of triphasic CT scan in
focal liver lesions and to determine its diagnostic accuracy. 
Patients and Methods
The study was simultaneously conducted in
Department of Diagnostic Radiology of Sind Institute of
Urology and Transplantation (SIUT) and Aga Khan
University Hospital. Data was collected from 15th February
2006 to 18 Feb 2007. All the patients of age over 18 years
with suspected focal hepatic lesion were included in the
study. There were 60 patients: 41 (68.3%) males and 19
(31.6%) females. Forty cases were taken from SIUT and 20
from AKU. Permission was sought from institutional ethical
review committees of both institutes. Informed consent was
taken from all the patients to enroll them in the study. Patients
who were pregnant at the time of the study or who had a
history of chronic renal failure were excluded. Focal fatty and
inflammatory lesions were also excluded along with 15 cases
in which histopathology was not available.
All the relevant features like age, sex, characterization
of lesion by CT and final histopathological characterization
and follow-up were recorded on a Performa.
Triphasic CT scanning of the liver was performed
with CTi/Pro GE Medical system and Toshiba X-Vision
single slicer CT scanner at 120 kvp and 200-250 mAs in
AKU and SIUT respectively. Patients were given I/V contrast
of 1.5 ml/Kg with overall dose ranging from 80-100 ml
according to departmental protocol. Patient preparation also
included administration of 2000 ml of water/gastrograffin 30-
60 minutes prior to the examination used as oral contrast.
After oral and injection of intravenous contrast
material, liver was scanned in arterial (scanning delay, 20-40
seconds), portal (scanning delay, 60-90 seconds), and
equilibrium (scanning delay, 2-5 minutes) phases.
Enhancement of each lesion in each phase was evaluated, and
the lesions were tabulated according to hyper enhancement,
hypo enhancement, iso-dense to liver parenchyma and mixed
enhancement pattern. 
On the basis of triphasic CT scan findings, lesions
were categorized as benign and malignant lesions. Benign
lesions like hepatic cysts appear hypodense and have no
enhancement in arterial, portovenous phase and equilibrium
phases. Haemangioma showed peripheral enhancement in
arterial phase and centripetal filling of contrast in portovenous
and equilibrium phase. Focal nodular hyperplasia and hepatic
adenoma have pattern of hyper enhancement, mixed and
mixed on arterial, portovenous and equilibrium phases
respectively. Hepatomas also have hyper enhancement,
iso/mixed enhancement and iso/mixed enhancing pattern in
arterial, portovenous and equilibrium phases respectively.
Hypervascular metastasis appears hyper enhancing on arterial
phase with mixed pattern on portovenous and equilibrium
phase. However, hypovascular metastasis appears
hypoenhancing on arterial phase and shows maximum
enhancement on portovenous phase. History and clinical
presentation were also considered for diagnosis.
All the images were interpreted by the consultant
radiologist having experience in CT reporting. Reporting was
done on console as well as hard copies. Histopathology was
performed in all 45 patients. In cases of multifocal lesion,
biopsy of the largest and most approachable lesion was
performed. 
False Positive cases in this study were defined as
lesions deemed malignant on triphasic CT scan but turned out
to be benign on histopathology. Similarly, False Negative can
be defined as lesions reported benign on triphasic CT scan but
were malignant on histopathology.
Data was entered and analyzed using Statistical
Package of Social Sciences (SPSS) programme version 10.0.
The diagnostic accuracy of spiral CT to identify focal liver
lesions as malignant or benign was calculated using SPSS
programme using histopathological findings and follow-up as
gold standard. 
Results
Overall 136 liver lesions, 11 benign and 125
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malignant were identified with the help of different
enhancement patterns and categorized into benign and
malignant lesion. Nineteen patients had unifocal and 26
patients had multifocal lesions in the liver. Patients having
mixed pattern i.e. both benign and malignant lesions were
categorized as having malignant lesions. 
Most common clinical presentation was jaundice
(32%) followed by pain (23%) and fever (15%). The mean
and standard deviation for age were 46.5 ± 13.4 years. Mean
lesion size was 3.4± 2.6 cm ranging from 0.9 to 13 cm. 
Out of 45 patients, 8 (17.8%) had benign while 37
(82.2%) had malignant lesions on CT Scan. Benign lesions
included haemangioma (n =3); adenoma (n =4) and FNH (n
=4). Malignant lesions were hepatoma (n =74) and
metastasis (n =51) (Table-2). Hepatomas were seen in 26
patients out of whom 23 patients had a history of chronic
liver disease from infective etiology like Hepatitis B, D and
C. Two patients gave a history of alcoholic liver disease
while in one patient cause was not known. All the
hepatomas were enhancing on arterial phase, out of which
54 were detected in arterial phase only. Nine lesions were
better seen in portovenous phase and 11 lesions were
hypoattenuating in portovenous phase. There were 30
hypervascular and 21 hypovascular metastatic lesions in 11
patients. Hypervascular metastasis were from renal cell
carcinoma (n =6), carcinoid (n =8), gastric tumours (n =6),
pancreatic tumours (n =6), sarcoma (n =3) and melanoma (n
=1). Hypovascular metastatic lesion were from lung (n =6),
breast (n =7), gastrointestinal tumours (n =3), lymphoma (n
=4) and endometrial cancer (n =1). 
On later histopathological examination, 35 (77.8%) of
the total 60 cases had malignant lesions while 10 (22.2%)
were diagnosed as benign lesions.
Thus there were 35 true positive, 2 false positive, 8
true negative and 0 false negative results reported on CT
based assessment of liver lesions (Table-2). Based on these
findings, triphasic CT Scan was found to have a sensitivity of
100 %, specificity of 80%, positive predictive value of
94.5%, negative predictive value of 100% and diagnostic
accuracy of 95.5 % in differentiating benign from malignant
liver lesions.
Discussion
Triphasic spiral liver Computed Tomography (CT) is
a standardized procedure for the detection and
characterization of a large variety of benign and malignant
liver lesions. This helps in the decline of mortality and
morbidity rates among patients with liver disease. Spiral
computed tomography has gained acceptance as the preferred
computed tomography technique for routine liver evaluation
because it provides image acquisition at peak enhancement of
liver parenchyma during a single breath hold.15,16 In addition
fast data acquisition allows successive scanning of the entire
liver at different intervals after injection of the iodinated
contrast material, thus creating the possibility of multiphase
liver computed tomography.17,18
Most metastases to the liver are hypovascular and
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Figure-1: Liver, metastases. Characteristic appearance of carcinoid liver metastases
on contrast-enhanced axial CT scan through the upper abdomen, which shows early
arterial enhancement of the liver metastases.
Figure-2: Hepatoma: Enhancing lesions in arterial phase with washout in
portovenous phase.
Table-1: Total No. of Lesions reported on Triphasic CT Scan.
Benign lesions Malignant lesions
Hemangioma = 3 Hepatoma = 74
Adenoma = 4 Metastasis = 51
FNH = 4
Table-2: Diagnostic Yield of Triphasic CT Scan.
CT Diagnosis Biopsy Report
Malignant Benign
Neoplastic 35 (True Positive) 2 (False Positive) 
Non-neoplastic 0 (False Negative) 8 (True Negative)
consequently are best detected during the portal venous
phase. Hypervascular primary malignancies (e.g.,
hepatocellular carcinomas) and certain metastases (e.g.,
pancreatic islet cell carcinomas, carcinoids, melanomas,
pheochromocytomas, choriocarcinomas, and sarcomas) have
a proportionately greater hepatic arterial blood supply and, as
a result, may be visible only on hepatic arterial phase
images.19 In our study, 30 metastatic lesions were
hypervascular and 21 lesions were hypovascular. Most of the
hypervascular metastatic lesions (n =24) were best visualized
on arterial phase images rather than on portovenous phase.
Most of them become iso or hypodense on portovenous and
equilibrium phases making it difficult to diagnose on single
phase thus signifying the importance of additional arterial
phase images.
Advanced or poorly differentiated hepatocellular
carcinomas are usually hypervascular lesions that derive
most of their blood supply from the hepatic artery with the
portal venous contribution decreasing as the grade of
malignancy increases. Similarly, cirrhosis and its associated
altered portal venous blood flow may help reveal more
lesions on the hepatic arterial phase than on the portal
venous phase. In our study, all the 74 hepatomas presented
as hyper/mixed/mixed; 54 detected only in the arterial
phase; 11 were hypoattenuating in the portal phase and 9
were better seen in portal phase. These findings are in
keeping with the well-known hypervascularity of HCC. All
hyper/mixed/mixed lesions occurring in patients with
chronic liver disease truly represent HCC lesions.14,16,20
Therefore; lesions seen during only the hepatic arterial
phase may require biopsy. In patients with hypervascular
malignancies such as hepatoma, detection of small lesions
especially if solitary is important because these lesions are
more likely to be resectable or respond to therapy than the
larger lesions.4,21
Focal nodular hyperplasia and adenomas may appear
hyperdense during the hepatic arterial phase and may
rapidly become isodense to the liver or invisible during the
portal venous phase and equilibrium phase, simulating
hepatomas or hypervascular metastases.19,22 We had very
few cases of focal nodular hyperplasia (FNH) and
adenomas diagnosed in our study and all of them were
hyperenhancing on arterial phase. Three lesions labeled as
adenomas became isodense on portovenous and equilibrium
phase. Similarly, one case of FNH was more conspicuous on
portovenous images. These lesions could have been easily
overlooked if only single phase imaging was acquired.
The triphasic helical CT examination can create
certain diagnostic dilemmas, including the inability to
specifically characterize some lesions seen only on the
hepatic arterial phase and not on the equilibrium or portal
venous phase. Although high accuracy (95%) was noted in
our results, we had 2 false positive results. These lesions were
labeled as malignant because of hypervascularity and
patient's history of renal cell carcinoma and gastrointestinal
malignancy. These lesions proved to be focal nodular
hyperplasia and haemangioma and not metastases.
Hepatomas, hypervascular metastases, focal nodular
hyperplasia and adenomas may all appear similar on triphasic
helical CT examination. In spite of this, our study showed
sensitivity of triphasic helical CT scan to be hundred percent
for differentiation of benign and malignant liver lesions.
There was no false negative case in our study. Possible causes
of false negative cases would be faulty imaging technique,
scans not done in true arterial, portovenous and delayed
phases, observer (Radiologist) interpretation error, lesions
less than 2 cm in size or lesions isodense to liver parenchyma
on all phases.
Our study has some limitations like small sample size
especially for benign lesions. Interobserver agreement for
interpretation of CT images was not calculated. In cases of
multifocal lesion, only biopsy of largest and most
approachable lesion was performed. Other potential
limitation is that scans were performed on two different CT
Scanners of different make. 
Conclusion
Triphasic CT scan is a good non-invasive tool and
can be used as first line imaging modality for
differentiating benign and malignant focal liver lesions.
Benign lesions like haemangioma can be reliably
differentiated from malignant liver lesion; therefore
unnecessary biopsies can be avoided. It is also particularly
useful for hypervascular lesions which can be easily
missed on routine CT scanning.
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